- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/52 - Oxygen atoms
Patent holdings for IPC class C07D 241/52
Total number of patents in this class: 46
10-year publication summary
1
|
2
|
5
|
3
|
6
|
5
|
0
|
1
|
0
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
California Institute of Technology | 3936 |
3 |
Development Center for Biotechnology | 131 |
2 |
National Institute of Biological Sciences, Beijing | 94 |
2 |
Sentinel Oncology Limited | 41 |
2 |
Universitetet I Oslo | 156 |
2 |
GOLDING, Louise | 57 |
2 |
Boehringer Ingelheim International GmbH | 4754 |
1 |
Industrial Technology Research Institute | 4959 |
1 |
Commissariat à l'énergie atomique et aux energies alternatives | 10692 |
1 |
Abbvie Inc. | 1782 |
1 |
Ampio Pharmaceuticals, Inc. | 36 |
1 |
Bergen Teknologioverforing AS | 80 |
1 |
Conatus Pharmaceuticals, Inc. | 11 |
1 |
Council of Scientific and Industrial Research | 608 |
1 |
Cytokinetics, Inc. | 268 |
1 |
Dr. Reddy's Laboratories Limited | 563 |
1 |
Genfit | 264 |
1 |
Histogen, Inc. | 14 |
1 |
Kyowa Hakko Kirin Co., Ltd. | 284 |
1 |
Mitsubishi Tanabe Pharma Corporation | 576 |
1 |
Other owners | 19 |